The Patent Finder

Esters for Treatment of Ocular Inflammatory Conditions

Johnson & Johnson Vision Care, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/503,158, filed Jun 30, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,865,685Esters for Treatment of Ocular Inflammatory Conditions
In force
 · High confidence
Johnson & Johnson Vision Care, Inc.In force
High confidence
US 10,588,887Esters for Treatment of Ocular Inflammatory Conditions
In force
 · Medium confidence
Johnson & Johnson Vision Care, Inc.In force
Medium confidence
US 11,096,919Esters for Treatment of Ocular Inflammatory Conditions
In force
 · Medium confidence
Johnson & Johnson Vision Care, Inc.In force
Medium confidence
US 11,311,510Esters for Treatment of Ocular Inflammatory Conditions
In force
 · Medium confidence
Johnson & Johnson Vision Care, Inc.In force
Medium confidence
US 12,364,679Esters for Treatment of Ocular Inflammatory Conditions
In force
 · Medium confidence
Johnson & Johnson Vision Care, Inc.In force
Medium confidence
US 10,383,839Esters for Treatment of Ocular Inflammatory Conditions
In force
 · High confidence
Johnson & Johnson Vision Care, Inc.In force
High confidence
Application 16/831,011Esters for Treatment of Ocular Inflammatory Conditions
Abandoned
Abandoned Aug 11, 2023
Johnson & Johnson Vision Care, Inc.AbandonedAbandoned Aug 11, 2023
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Johnson & Johnson Vision Care, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited